Persistent inflammation subverts thrombospondin-1-induced regulation of retinal angiogenesis and is driven by CCR2 ligation

Mei Chen, David A Copland, Jiawu Zhao, Jian Liu, John V Forrester, Andrew D Dick, Heping Xu

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Neovascular retinal disease is a leading cause of blindness orchestrated by inflammatory responses. Although noninfectious uveoretinitis is mediated by CD4(+) T cells, in the persistent phase of disease, angiogenic responses are observed, along with degeneration of the retina. Full clinical manifestation relies on myeloid-derived cells, which are phenotypically distinct from, but potentially sharing common effector responses to age-related macular degeneration. To interrogate inflammation-mediated angiogenesis, we investigated experimental autoimmune uveoretinitis, an animal model for human uveitis. After the initial acute phase of severe inflammation, the retina sustains a persistent low-grade inflammation with tissue-infiltrating leukocytes for over 4 months. During this persistent phase, angiogenesis is observed as retinal neovascular membranes that arise from inflamed venules and postcapillary venules, increase in size as the disease progresses, and are associated with infiltrating arginase-1(+) macrophages. In the absence of thrombospondin-1, retinal neovascular membranes are markedly increased and are associated with arginase-1(-) CD68(+) macrophages, whereas deletion of the chemokine receptor CCR2 resulted in reduced retinal neovascular membranes in association with a predominant neutrophil infiltrate. CCR2 is important for macrophage recruitment to the retina in experimental autoimmune uveoretinitis and promotes chronicity in the form of a persistent angiogenesis response, which in turn is regulated by constitutive expression of angiogenic inhibitors like thrombospondin-1. This model offers a new platform to dissect the molecular and cellular pathology of inflammation-induced ocular angiogenesis.
Original languageEnglish
Pages (from-to)235-245
Number of pages11
JournalAmerican Journal of Pathology
Volume180
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Thrombospondin 1
Ligation
Inflammation
Retina
Arginase
Venules
Macrophages
Membranes
Retinal Diseases
Angiogenesis Inhibitors
Molecular Pathology
Chemokine Receptors
Uveitis
Macular Degeneration
Myeloid Cells
Blindness
Neutrophils
Leukocytes
Animal Models
T-Lymphocytes

Keywords

  • Animals
  • Cytokines
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Mice
  • Mice, Inbred C57BL
  • Receptors, CCR2
  • Retinal Neovascularization
  • Retinitis
  • Thrombospondin 1
  • Uveitis

Cite this

Persistent inflammation subverts thrombospondin-1-induced regulation of retinal angiogenesis and is driven by CCR2 ligation. / Chen, Mei; Copland, David A; Zhao, Jiawu; Liu, Jian; Forrester, John V; Dick, Andrew D; Xu, Heping.

In: American Journal of Pathology, Vol. 180, No. 1, 01.2012, p. 235-245.

Research output: Contribution to journalArticle

Chen, Mei ; Copland, David A ; Zhao, Jiawu ; Liu, Jian ; Forrester, John V ; Dick, Andrew D ; Xu, Heping. / Persistent inflammation subverts thrombospondin-1-induced regulation of retinal angiogenesis and is driven by CCR2 ligation. In: American Journal of Pathology. 2012 ; Vol. 180, No. 1. pp. 235-245.
@article{78159fb6797540cfa8ea8dd1a59c3e3c,
title = "Persistent inflammation subverts thrombospondin-1-induced regulation of retinal angiogenesis and is driven by CCR2 ligation",
abstract = "Neovascular retinal disease is a leading cause of blindness orchestrated by inflammatory responses. Although noninfectious uveoretinitis is mediated by CD4(+) T cells, in the persistent phase of disease, angiogenic responses are observed, along with degeneration of the retina. Full clinical manifestation relies on myeloid-derived cells, which are phenotypically distinct from, but potentially sharing common effector responses to age-related macular degeneration. To interrogate inflammation-mediated angiogenesis, we investigated experimental autoimmune uveoretinitis, an animal model for human uveitis. After the initial acute phase of severe inflammation, the retina sustains a persistent low-grade inflammation with tissue-infiltrating leukocytes for over 4 months. During this persistent phase, angiogenesis is observed as retinal neovascular membranes that arise from inflamed venules and postcapillary venules, increase in size as the disease progresses, and are associated with infiltrating arginase-1(+) macrophages. In the absence of thrombospondin-1, retinal neovascular membranes are markedly increased and are associated with arginase-1(-) CD68(+) macrophages, whereas deletion of the chemokine receptor CCR2 resulted in reduced retinal neovascular membranes in association with a predominant neutrophil infiltrate. CCR2 is important for macrophage recruitment to the retina in experimental autoimmune uveoretinitis and promotes chronicity in the form of a persistent angiogenesis response, which in turn is regulated by constitutive expression of angiogenic inhibitors like thrombospondin-1. This model offers a new platform to dissect the molecular and cellular pathology of inflammation-induced ocular angiogenesis.",
keywords = "Animals, Cytokines, Humans, Intercellular Signaling Peptides and Proteins, Mice, Mice, Inbred C57BL, Receptors, CCR2, Retinal Neovascularization, Retinitis, Thrombospondin 1, Uveitis",
author = "Mei Chen and Copland, {David A} and Jiawu Zhao and Jian Liu and Forrester, {John V} and Dick, {Andrew D} and Heping Xu",
note = "Copyright {\circledC} 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.",
year = "2012",
month = "1",
doi = "10.1016/j.ajpath.2011.09.020",
language = "English",
volume = "180",
pages = "235--245",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Persistent inflammation subverts thrombospondin-1-induced regulation of retinal angiogenesis and is driven by CCR2 ligation

AU - Chen, Mei

AU - Copland, David A

AU - Zhao, Jiawu

AU - Liu, Jian

AU - Forrester, John V

AU - Dick, Andrew D

AU - Xu, Heping

N1 - Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

PY - 2012/1

Y1 - 2012/1

N2 - Neovascular retinal disease is a leading cause of blindness orchestrated by inflammatory responses. Although noninfectious uveoretinitis is mediated by CD4(+) T cells, in the persistent phase of disease, angiogenic responses are observed, along with degeneration of the retina. Full clinical manifestation relies on myeloid-derived cells, which are phenotypically distinct from, but potentially sharing common effector responses to age-related macular degeneration. To interrogate inflammation-mediated angiogenesis, we investigated experimental autoimmune uveoretinitis, an animal model for human uveitis. After the initial acute phase of severe inflammation, the retina sustains a persistent low-grade inflammation with tissue-infiltrating leukocytes for over 4 months. During this persistent phase, angiogenesis is observed as retinal neovascular membranes that arise from inflamed venules and postcapillary venules, increase in size as the disease progresses, and are associated with infiltrating arginase-1(+) macrophages. In the absence of thrombospondin-1, retinal neovascular membranes are markedly increased and are associated with arginase-1(-) CD68(+) macrophages, whereas deletion of the chemokine receptor CCR2 resulted in reduced retinal neovascular membranes in association with a predominant neutrophil infiltrate. CCR2 is important for macrophage recruitment to the retina in experimental autoimmune uveoretinitis and promotes chronicity in the form of a persistent angiogenesis response, which in turn is regulated by constitutive expression of angiogenic inhibitors like thrombospondin-1. This model offers a new platform to dissect the molecular and cellular pathology of inflammation-induced ocular angiogenesis.

AB - Neovascular retinal disease is a leading cause of blindness orchestrated by inflammatory responses. Although noninfectious uveoretinitis is mediated by CD4(+) T cells, in the persistent phase of disease, angiogenic responses are observed, along with degeneration of the retina. Full clinical manifestation relies on myeloid-derived cells, which are phenotypically distinct from, but potentially sharing common effector responses to age-related macular degeneration. To interrogate inflammation-mediated angiogenesis, we investigated experimental autoimmune uveoretinitis, an animal model for human uveitis. After the initial acute phase of severe inflammation, the retina sustains a persistent low-grade inflammation with tissue-infiltrating leukocytes for over 4 months. During this persistent phase, angiogenesis is observed as retinal neovascular membranes that arise from inflamed venules and postcapillary venules, increase in size as the disease progresses, and are associated with infiltrating arginase-1(+) macrophages. In the absence of thrombospondin-1, retinal neovascular membranes are markedly increased and are associated with arginase-1(-) CD68(+) macrophages, whereas deletion of the chemokine receptor CCR2 resulted in reduced retinal neovascular membranes in association with a predominant neutrophil infiltrate. CCR2 is important for macrophage recruitment to the retina in experimental autoimmune uveoretinitis and promotes chronicity in the form of a persistent angiogenesis response, which in turn is regulated by constitutive expression of angiogenic inhibitors like thrombospondin-1. This model offers a new platform to dissect the molecular and cellular pathology of inflammation-induced ocular angiogenesis.

KW - Animals

KW - Cytokines

KW - Humans

KW - Intercellular Signaling Peptides and Proteins

KW - Mice

KW - Mice, Inbred C57BL

KW - Receptors, CCR2

KW - Retinal Neovascularization

KW - Retinitis

KW - Thrombospondin 1

KW - Uveitis

U2 - 10.1016/j.ajpath.2011.09.020

DO - 10.1016/j.ajpath.2011.09.020

M3 - Article

C2 - 22067906

VL - 180

SP - 235

EP - 245

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 1

ER -